Real-World Outcomes

Patients with hepatocellular carcinoma who took a reduced therapy dose had a lower cumulative pill cost and were less likely to discontinue treatment due to toxicities.
Researchers compared the relationship between randomized controlled clinical trial efficacy data and real-world effectiveness for oncology therapies.
Recent research suggests that 73% of patients with cancer do not discuss the cost of care with their care team.
Cancer patients receiving chemotherapy should have all their medications and herbal supplements reviewed by a pharmacist who specializes in cancer therapy, researchers say.
Hospital-based end-of-life care for older patients with malignant brain tumors is associated with over $16,000 in expenses per patient.